Entera Bio Ltd.
News
Contrasting Entera Bio (NASDAQ:ENTX) & Inhibikase Therapeutics (NYSE:IKT)
Ticker Report Entera Bio (NASDAQ:ENTX - Get Free Report) and Inhibikase Therapeutics (NYSE:IKT - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two...\n more…
Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?
Zacks Investment Research For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Entera Bio Ltd. (ENTX) is a stock that can certainly grab the...\n more…
Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update
Ticker Report Entera Bio Ltd. (NASDAQ:ENTX - Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 15th, there was short interest totalling 27,800...\n more…
Entera Bio to Participate in Upcoming Investor and Scientific Conferences
Globe Newswire JERUSALEM, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), ( Entera or the Company ) a leader in the development of orally delivered peptides and small therapeutic proteins...\n more…
All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy
Zacks Investment Research Entera Bio Ltd. (ENTX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates...\n more…